RARE
Ultragenyx Pharmaceutical Inc
Price:  
40.34 
USD
Volume:  
407,482.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE WACC - Weighted Average Cost of Capital

The WACC of Ultragenyx Pharmaceutical Inc (RARE) is 7.7%.

The Cost of Equity of Ultragenyx Pharmaceutical Inc (RARE) is 10.40%.
The Cost of Debt of Ultragenyx Pharmaceutical Inc (RARE) is 5.00%.

Range Selected
Cost of equity 8.20% - 12.60% 10.40%
Tax rate 0.50% - 0.70% 0.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 8.8% 7.7%
WACC

RARE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.94 1.37
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 12.60%
Tax rate 0.50% 0.70%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 8.8%
Selected WACC 7.7%